John N. Primrose

p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.

Hdm2 recruits a hypoxia-sensitive corepressor to negatively regulate p53-dependent transcription.

Adenoid Cystic Carcinoma of the lacrimal gland metastasising to the liver: report of a case.

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation.

A comparison of primary oesophageal squamous epithelial cells with HET-1A in organotypic culture.

Short- and long-term outcomes after laparoscopic and open hepatic resection: systematic review and meta-analysis.

Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983).

Exploring the role of laparoscopic surgery in two-stage hepatectomy for bilobar colorectal liver metastases.

Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors.

Assessment of the financial implications for laparoscopic liver surgery: a single-centre UK cost analysis for minor and major hepatectomy.

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.

T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases.